# Re-treatment 225Ac-J591 for mCRPC

> **NCT04576871** · EARLY_PHASE1 · COMPLETED · sponsor: **Weill Medical College of Cornell University** · enrollment: 6 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** 225Ac-J591

## Key facts

- **NCT ID:** NCT04576871
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-29
- **Primary completion:** 2023-08-31
- **Final completion:** 2024-05-31
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2025-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04576871

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04576871, "Re-treatment 225Ac-J591 for mCRPC". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04576871. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*